We have studied potential regulatory interactions between mature B lymphocyte populations by analysis of C.B-17 severe combined immunodeficient (SCID) mice reconstituted simultaneously with immunoglobulin allotype-congenic mixtures of spleen (SP) and peritoneal cavity (PerC) B cells. We have previously shown that the independent transfer of B cells from these sources leads to the long-term survival of donor B cells and reconstitution of immunoglobulin levels in SCID mice (Riggs, J. lymphocytes isolated from adult mice show evidence of heterogeneity in a large number offunctional and phenotypic assays (1-11) . These observations give rise to three questions : (a) are distinct functions associated with distinct B cell subsets ; (b) do distinct lineages of B cell development exist (e.g., in a sense analogous to T cells expressing a/(3 or y/S receptors) ; and (c) do different B cell subsets (or lineages) influence each other? Historically, these questions first focused on B cells responsive to thymus-dependent (TD)1 versus thymus-independent (TI) antigens (1), then on B cells expressing or not expressing , and the current can1Abbreviations used in this paper.' HRP, horseradish peroxidase ; PC, phosphorylcholine ; PerC, peritoneal cavity; PVC, polyvinylchloride; SP, spleen ; TD, thymus-dependent ; TI, thymus-independent .
Summary
We have studied potential regulatory interactions between mature B lymphocyte populations by analysis of C.B-17 severe combined immunodeficient (SCID) mice reconstituted simultaneously with immunoglobulin allotype-congenic mixtures of spleen (SP) and peritoneal cavity (PerC) B cells. We have previously shown that the independent transfer of B cells from these sources leads to the long-term survival of donor B cells and reconstitution of immunoglobulin levels in SCID mice (Riggs, J.E., D.L. Robertson, R.S. Stowers, and D.E. Mosier, manuscript submitted for publication). SP and PerC B cells differ in numerous respects, with the PerC having higher proportions of large, activated B cells that express the IgM>IgD phenotype and greater numbers ofCD5 B cells . The injection of equal numbers of B cells from SP and PerC into SCID recipients (e.g., BALB/c SP + C.B-17 Per C -SCID) has led to the following observations : (a) serum IgM allotypes in B cell chimeras revealed strict dominance by the allotype contributed by the PerC B cells; (b) this dominance was not due to regulatory T cells ; (c) B cells of the unexpressed (i.e., SP) allotype were present in the chimera in the spleen but not the peritoneal cavity; and (d) immunization with TI and TD antigens failed to elicit the SP IgM allotype, whereas secondary TD antigen immunization elicited low levels of the SP IgG2a allotype. Additional experiments demonstrated concurrent expression of IgM allotypes derived from both SP and PerC B cells in recipients that: (a) received a 10-fold excess of SP B cells; (b) received SP B cells before PerC B cell transfer; or (c) received SP B cells intravenously and PerC B cells intraperitoneally. We conclude that the establishment of IgM synthesis by PerC B cells leads to a feedback inhibition of subsequent IgM synthesis by SP B cells, and that the frequency of B cells that can lead to this effect is substantially higher in peritoneal cavity than in spleen. These data provide further confirmation of regulatory interactions between B cells in the absence of T lymphocytes (18) , but confound the interpretation of experiments supporting the existence of a separate CD5+ B cell lineage (9) . lymphocytes isolated from adult mice show evidence of heterogeneity in a large number offunctional and phenotypic assays (1-11) . These observations give rise to three questions : (a) are distinct functions associated with distinct B cell subsets ; (b) do distinct lineages of B cell development exist (e.g., in a sense analogous to T cells expressing a/(3 or y/S receptors) ; and (c) do different B cell subsets (or lineages) influence each other? Historically, these questions first focused on B cells responsive to thymus-dependent (TD)1 versus thymus-independent (TI) antigens (1), then on B cells expressing or not expressing Lyb-5 (12) , and the current can1Abbreviations used in this paper.' HRP, horseradish peroxidase ; PC, phosphorylcholine ; PerC, peritoneal cavity; PVC, polyvinylchloride; SP, spleen ; TD, thymus-dependent ; TI, thymus-independent .
didates of conventional B cells and CD5 (Ly-1)-positive B cells (8) . Characterization of peritoneal cavity (PerC) CD5+ B cells has provided the following evidence in support of their being a distinct B cell subpopulation/lineage . These cells exhibit a specific array of cell surface antigens [CD5+/ -, Mac-1 + , IgM>IgD, 132201-(7, 8)], express unique V genes (13), have a distinct s1g+ progenitor (9) , and display unique functional properties such as spontaneous Ig secretion (8), responsiveness to "environmental" antigens (8, 14) , unresponsiveness to TD antigens (15) , and autoantibody production (7, 15) . However, controversy exists as to the stability of the CD5+ phenotype, as evidence accumulates that this marker is also an activation antigen (7, 8, 16, 17) . Precursors of CD5+ B cells in adult animals appear to exist in the PerC but not the bone marrow (9) , which is the clearest argument for their being a separate lineage . Our previous work (Riggs, J.E., D.L. Robertson, R.S. Stowers, and D.E. Mosier, manuscript submitted for publication) described the survival and function of mature B cells from different lymphoid organs when transferred to C.B-17 scid (SCID) mice, and documented engraftment ofboth conventional B cells and large, high slgM, Mac-1 + B cells that are identical to or closely related to the CD5+ (or their CD5' "sisters") population. The engraftment of the latter population was seen with transfer of all B cell sources studied, including bone marrow from aged animals. This paper focuses on the interaction of allotypemarked B cells derived from spleen (SP) and from PerC when both are cotransferred to SCID recipients.
Our results extend recent experiments (18) suggesting feedback inhibition of Ig synthesis by CD5-like B cells derived from the PerC. We find that the Ig allotype derived from PerC B cells dominates over the allotype associated with transferred SP B cells. This allotype dominance is not dependent upon T cells, and appears to interfere with Ig synthesis rather than B cell survival. B cells capable of mediating feedback suppression exist both in the spleen and PerC; they are simply more frequent in the latter site. These studies have implications for the issue of separate B cell lineages as well as for regulatory interactions among B cells .
Materials and Methods
Mice. BALB/c (H-2d, Igh') and BALB.xid (XID), C.B-17 (H-2d, Ighb), and C.B-17-scid (hereafter, SCID) mice, bred and maintained at the Medical Biology Institute (MBI), were used between 8 and 12 wk of age. All donors were age-and sex-matched for establishing chimeras. All mice were handled in accord with National Institutes ofHealth (NIH) guidelines . The MBI SCID colony was derived from breeding pairs kindly provided by Ken Dorschkind, UC Riverside . As 10% of SCID mice "break through" and produce Ig, all mice were bled at 8 wk of age and only those mice with <5 14g/ml of serum IgM were used in these studies .
CellPreparations andAdoptive Transfer. SP suspensions were prepared by gently mincing spleens between two sterile glass slides in HBSS. PerC cells were harvested by flushing the peritoneum with 10 ml HBSS. T cells were depleted by antiThy-1.2 plus complement treatment . Unless specified otherwise, a total of 10 x 106 cells in a volume of 0.2 mls of HBSS (5 x 106 of each allotype) were injected intravenously into the lateral tail vein or intraperitoneally into SCID recipients.
Antigens and Immunizations. 0.3 ml (ti101 organisms) of a heat-killed Streptococcus pneumoniae (strain R36a, obtained from American Type Culture Collection [ATCC1, Rockville, MD) preparation and 100 kg of cr(1 --i 3) dextran (Dextran, B1355S) in saline, generously provided by the laboratory ofDr. Roy Riblet (MBI), were simultaneously injected intraperitoneally with 100 wg KLH . (Calbiochem-Behring Corp., La Jolla, CA) in saline mixed with CFA (H37Ra; Difco Laboratories, Detroit, MI), or 50 Etg phosphorylcholine (PC)-substituted KLH, prepared as described (19) and mixed with IFA (Sigma Chemical Co., St. Louis, MO), were injected intraperitoneally.
Allotype-and Antigen-specific ELISA. Allotype-specific serum IgM levels were determined by ELISA employing flexible polyvinylchloride (PVC) plates (Dynatech Laboratories, Alexandria, VA) coated with an appropriate dilution of affinity-purified rabbit
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Peritoneal Cavity B Cell Dominance in SCID Recipients anti-mouse IgM antibody. Serial twofold dilutions of test sera and the standard HPCM2 (IgM', «) for IgM' or total serum IgM detection, or C.B-17 sera for IgMb detection were applied in duplicate to the plates. Total IgM or Ig levels were determined using an appropriate dilution of rabbit anti-mouse Ig F(ab')a-specific horseradish peroxidase (HRP) conjugate (Jackson ImmunoResearch Laboratories, Inc., Avondale, PA) . IgM' and IgMb levels were determined, respectively, with biotinylated (20) (19) , or dextran-substituted BSA, the latter generously provided by Dr. Gary Gilmore (MBI). HPCM2 and MOPC-104E (IgM, X) served as IgM anti-PC and IgM anti-Dextran standards . PC-specific antibodies were detected with the rabbit anti-mouse Ig F(ab')z-specific HR.P conjugate described above. Dextran-specific antibodies were detected with an appropriate dilution of goat anti-mouse X alkaline-phosphataseconjugate (Fisher Biotech), with phenolphthalein monophosphate serving as the substrate . Calculations of all Ig levels were done by comparison to standard curves using a minimum of 5 data points with correlation coefficients >0.95 .
Flow Cytometric Analyses. SP "or PerC cells were treated with Tris-buffered NH4C1 to lyse red blood cells. 106 cells were then incubated with various airfuged (100,000g for 10 min) antibody preparations . T cells were detected with fluoresceinated antiThy-1.2 obtained from Becton Dickenson Immunocytometry Systems, Mountain View, CA. Total IgM* cells were detected with fluoresceinated goat anti-mouse IgM antibody (Fisher Biotech). Sequential incubations, first with biotinylated, protein A-purified DS-1 or AFS-78.25 followed by avidin-FITC (Fisher Biotech) were used to detect IgM' or IgMb bearing cells. An appropriate dilution of biotinylated AF6-122 (mouse IgG, anti-IgD" [22) , Pharmingen) followed by streptavidin-FITC (Fisher), or a saturating amount of AMS 9.1.1.1 (mouse IgG2b anti-IgD' [221) tissue culture supernatant followed by a predetermined amount of fluoresceinated goat anti-mouse IgG2b (Fisher Biotech) were used to detect IgD allotypes. Each step was conducted on ice for 30 min with extensive washing between steps . All samples included propidium iodide to allow exclusion of dead cells from the analyses. A minimum of 3 x 104 cells were then analyzed on a Coulter EPICS 753 flow cytometer.
Results
IgM Produced by PerC B Cells Dominates after Co-transfer of Allotype-Congenic SP and PerC to SCID Mice. We have previously shown that PerC B cells restore serum Ig levels in SCID recipients more rapidly than do SP B cells (Riggs, J.E., et al., manuscript submitted for publication). Given this result, it is ofinterest to determine if the simultaneous intravenous transfer ofmixtures of SP and PerC cells leads to partial or total dominance ofIg produced by the PerC cells. We used transfers of Ig-allotype marked cell populations to perform these co-transfer experiments. All combinations of SP and PerC cells from C.B-17 (Ighb) and BALB/c (Igha) donors were transferred to SCID mice. The recipients were bled weekly after intravenous transfer of cells, and their sera were assayed by ELISA for levels of total IgM, IgM°, and IgMb. The results of a representative experiment are presented in Table 1 . The co-transfer of cells from the same tissue source (e.g., SP' + SPb) led to almost equal representation of each IgM allotype in the serum of the SCID chimera . However, the co-transfer of SP and PerC cells led to dominance by IgM expressing the allotype of the PerC donor. This dominance was stable as it persisted in mice for at least 60 wk after cell transfer (not shown) .
T Cells Are Not Responsible for the Dominance ofthe PerC Allotype. Dominance of the PerC-contributed allotype in PerC + SP chimeras could be the result of regulatory T cell influences (24) . To test this possibility, SP and PerC preparations were treated with antiThy-1 .2 plus complement to deplete T cells before co-transfer to SCID recipients. Table 2 illustrates that T cell depletion did not alter the dominance of the IgM allotype contributed by the PerC B cells. The completeness of T cell depletion was confirmed by experiments in which SCID recipients ofT cell-depleted mixtures of PerC and SP were killed at weekly intervals and tested for the presence of T cells by PHA responsiveness and flow cytometric analyses. In no instance was there any evidence of T cells by both criteria for at least 6 wk after transfer (data not shown) . As a further test of the hypothesis that the dominance exerted by PerC cells was attributable to B cells and not T cells, we used BALB.xid mice as PerC B cell donors. xid mice have an intrinsic B cell defect manifest at several levels, including reduced serum IgM levels (6), but their T cells are normal in most respects (25) . Equal numbers (5 x 106) of B cells from BALB.xid PerC and C.B-17 SP were injected intravenously into SCID recipients . The results shown in Table 3 Riggs et al. Table 4 were derived. Splenic B cells from PerCb + SP' allotype chimeras predominately expressed mIgM and mIgD of the SP donor allotype (Table  4 ; Fig. 1, A, E , C, G), although some B cells expressed IgMb and thus were derived from the PerC donor. In contrast, PerC B cells from the same mice had a relative predominance of IgMb cells derived from the PerC donor (Table 4 deliberate immunization. SCID recipients of PerCb + SP' B cells were immunized 10 wk after transfer with R36a (S. pneumoniae) to elicit anti-PC antibodies and with dextran B1355S to elicit anti-ca (1 -3) dextran antibodies. Igh' mice respond to dextran, while Ighb mice do not (26) . Use of allotype-specific reagents to develop antigen-specific ELISAs permits assessment of the contribution of each donor allotype in the response to PC. The results in Table 5 show that SP' + SPb and PerC' + PerCb recipients had relatively equal representation ofeach allotype in their IgM anti-PC response. In contrast, both the PerC' + SPb and the PerCb + SP' recipients showed relative dominance of PC antibodies contributed by the PerC B cell donor. 14) . Accordingly, we also tested the ability ofTD antigens to rescue the "suppressed" SP allotype . PerC + SP (not Tdepleted) chimeras, BALB/c, C.B-17, and unreconstituted SCID controls were primed with 100 pg KLH 4 wk after transfer and boosted with 50 ,ug PC-KLH 4 wk later. The augmented primary antibody response to PC and the secondary antibody response to KLH were assayed 7 d after immunization . The primary IgM response to PC is restricted to the IgM bearing the PerC allotype (Table 6 ). Similar results were obtained for primary immune sera after KLH and SRBC immunization (data not shown) . As these mice were carrier-primed to enhance T cell help for the primary anti-PC response, we also tested their secondary IgM' and IgMb anti-KLH response. While the secondary response to KLH was quite low in these animals, the IgM allotype contributed by PerC cells appear to predominate although a small amount of the SP IgM allotype was now detectable. Furthermore, when the IgG2a' response to KLH was measured, a better antibody response was seen and the SP allotype was readily detectable . Comparison between groups suggests that the major part of this response came from B cells derived from the SP donor. These data suggest that the PerC IgM allotype is predominant in both primary and secondary responses to TD antigens, yet the SP IgG2a allotype is elicited in a secondary TD response . This result suggests that the "suppressed" B cell is present and indicates that it can be activated by antigen under appropriate circumstances .
Secondary Transfer to SCID Recipients Fails to Rescue the "Suppressed" SP Allotype We performed secondary transfer experiments to address two issues : (a) how stable is the suppression of SP B mediated by PerC B; and (b) do all the cells capable ofmaintaining suppression exist in the spleen of the primary SCID recipient, or might transfer of cells from the (Table  7) . PerC allotype dominance in secondary recipients was stable as similar results were observed at 30 wk after transfer. Sec- Table 9 show that this is the case; equal representation of both allotypes is detected in recipients of equal numbers of large PerC and SP B cells. These data confirm that the spleen harbors B cells capable of competing with PerC B cells and suggest that the SP B cells that mediate this dominance are enriched in a large B cell fraction.
Sequential Transfer ofPerC B Cells to SCID Mice Previously Reconstituted with SP B Cells Results in Co-expression ofBoth A1lotypes. The results presented above indicate that differences in rates of B cell growth or Ig secretion may explain PerC B cell dominance in PerC + SP chimeras. To test this hypothesis, sequential transfers were conducted in which SCID recipients of SP B cells received PerC B cells 5 wk later. This sequential transfer protocol should result in the establishment of B cells from the initial source, effectively negating growth rate differences, which permits an assessment of the ability of the second B cell source to compete with the established primary graft . Table 10 illustrates results for experiments in   481 Riggs et al.
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' Serum IgM levels determined 10 wk after transfer by ELISA . Injection Route Influences B Cell-mediatedAllotype Dominance Early after Transfer. Our previous studies have shown that intraperitoneal transfer reduced the marked differences in IgM and B cell reconstitution rates noted after intravenous transfer of SP and PerC B cells (Riggs, J.E., et al., manuscript submitted for publication) . In addition, the above results (e.g., Table 7 ) led to the question of whether the majority of the B cells mediating allotype dominance ended up in the spleen versus the PerC of SCID recipients. To address these issues, PerC' and SPb cells were co-transferred in all possible combinations ofintravenous and intraperitoneal routes. The data in Table 11 demonstrate that transient allotype dominance mediated by the SP donor was evident in recipients of SPb intravenously and PerC' intraperitoneally at 2 wk after transfer, but not at 10 wk after transfer. All other combinations of injection routes led to allotype dominance by the PerC donor. These results suggest that the PerC of the recipient is not the only or primary site of residence of the B cells responsible for allotype suppression, and further suggest that the mechanism of suppression may require relatively close proximity of the B cells mediating suppression and those being suppressed . selective survival of certain long-lived lymphoid subsets, and potential contributions by endogenous SCID NK cells (27) to the survival or function of donor lymphocytes . Despite these considerations, the results presented in this paper further our understanding of B lymphocyte function and longevity, and document potentially important regulatory interactions between B cells. The main findings presented in this paper are that feedback inhibition ofspontaneous and antigen-induced IgM secretion can be mediated by B cells that exist in higher frequency in the PerC as compared with the SP. In co-transfer ofPerC and SP B cells from allotype-disparate donors, this feedback inhibition is manifest as a failure of the IgM . allotype of the SP donor to be detected in the serum of SCID recipients . B cells from PerC can also exert feedback inhibition on allotype-mismatched PerC B cells transferred subsequently to the same SCID recipients . Feedback inhibition or B cell-mediated allotype dominance does not appear to require T lymphocytes . B cells capable of mediating allotype dominance are found both in the PerC and the spleen of normal BALB/c or C.B-17 donors (albeit at different frequencies), but are absent or substantially reduced in BALB.xid donors. Feedback inhibition probably affects primarily Ig synthesis or secretion, since significant numbers of B cells expressing the "suppressed" allotype can be detected in the spleens, but not in the peritoneal cavity, ofallotype chimeric SCID mice. However, the possibility that a small but important fraction ofB cells of the "suppressed" allotype are missing in the PerC + SP B cell chimeras cannot be excluded. Independent but simultaneous transfer of PerC cells to the peritoneal cavity (intraperitoneal injection) and SP cells to the spleen (intravenous injection) leads to a delayed onset ofallotype dominance by the PerC cells, suggesting that feedback inhibition is not mediated by a secreted product such as Ig, and instead may require either cell contact or close proximity. Sera from SCID recipients showing allotype dominance do not transfer dominance to secondary recipients (data not shown), whereas secondary transfer ofB cells does maintain allotype dominance (Table 7) .
The B cells responsible for allotype dominance in our experiments share several characteristics with the CD5' (and their CD5' "sisters") B cell population (7, 8): (a) they are present in the spleen at a lower frequency than in the peritoneal cavity ; (b) they are enriched in "large" B cell fractions ; (c) they preferentially repopulate the peritoneal cavity; (d) they are long-lived; and (e) they appear to account for the majority of spontaneous IgM . secretion, as has been noted previously (8) . As noted in previous studies (Riggs, J.E., et al., manuscript submitted for publication), CD5 expression is not a reliable marker of this population following transfer to SCID recipients, but the general concept that a CD5-like subset with high representation in PerC is the primary mediator offeedback inhibition is attractive. Feedback inhibition mediated by CD5+ B cells has recently been reported by Lalor et al. (18) under different experimental conditions . An antiIgMb mAb was used to temporarily block development of B cells in C.B-17 neonatal mice; subsequent injection ofsorted Ly-1 + BALB/c B cells led to a long-term decrease in both 48 3
Riggs et al, endogenous Ly-1+ B cells and IgM of host origin. In contrast to our results, however, the reduction in cell numbers was more impressive than the reduction in IgMb levels . Raveche et al. (28) also have reported that hyperdiploid CD5+ B cells from old NZB mice downregulate'both endogenous B cell numbers and IgM secretion in unirradiated young (NZB x DBA/2) Fl recipients. A similar type of feedback inhibition has been postulated to be involved in multiple myeloma patients, although the mechanism of this inhibition remains to be elucidated (29) . The finding that mice with the xid mutation have reduced numbers of CD5 B cells and accept long-term grafts of normal B cells without prior irradiation (8, 30) is also consistent with a role for CD5 B cells in feedback inhibition . The allotype dominance seen in the co-transfer of PerC and SP B cells could have alternative explanations that do not involve feedback inhibition . The simultaneous transfer of two B cell populations to a SCID recipient creates a competition in many ways analogous to the competition of two species for a restricted habitat . The more rapid expansion of one population, even if their advantage is small, may lead to the extinction of the other population. Many observations in our experiments are consistent with a growth advantage of PerC B cells, but one experiment suggests that this explanation may be insufficient . The sequential transfer of SP cells followed by PerC cells led to a replacement of the originally engrafted SP B cells by PerC B cells, with a transition phase when both allotypes are expressed. In contrast to this result, the simultaneous transfer ofa 9:1 excess of SP to PerC B cells led to a long-lived dominance of the SP B cell allotype. These apparently conflicting results could be explained if the act ofB cell isolation and transfer led to cell activation, such that delayed transfer ofPerC B cells led to a competition between activated PerC B cells and less activated (established) B cells ofSP origin. In contrast, both populations would be subject to activation in the simultaneous 9:1 SP/PerC transfer experiment. While the simplest explanation for our results is the competition of two populations for a limited B cell microenvironment, these experiments do raise the question of whether B cell allotype dominance reflects a direct competition, competition in addition to feedback inhibition, or both. Direct competition could reflect limitations in the availability ofsuitable microenvironments for B cell engraftment (e.g., the marginal zone of spleen where CD5 B cells appear to reside [8]) or competition for limited amounts ofcytokines necessary for B cell differentiation. Feedback inhibition would appear from our experiments to involve either direct cell-tocell contact or close proximity, and cannot be mediated by passive transfer of serum, so it is unlikely that Ig mediates the inhibition .
Our results do not allow resolution of the issue of independent conventional and CD5 + B cell lineages as first proposed by Hayakawa et al. (9) , but they do call into question the interpretation ofthose experiments. Iftransfer of one population enriched for CD5 B cells can block development or Ig synthesis by another, then an experiment in which allotypemarked Ly-1 B cells are transferred to an irradiated recipient and result in dominant expression of that allotype (9) does not necessarily coincide with the interpretation that Ly-1 B cells represent a separate lineage. Our data do not eliminate this possibility ; we simply point out that it remains an open issue.
The important and unresolved question is the extent to which competition between B cell subsets influences the normal pattern of B cell development in intact mice . CD5 B cells are prominent in neonatal life (8), yet they obviously do not maintain that dominance in any site other than the PerC . Nonetheless, our results imply that the first wave of B cell differentiation could have profound effects on any B cells that develop subsequently, and that such effects are not necessarily mediated by idiotypic networks (31) . If these effects
